Eslidin Capsules, # 30

Hard gelatin capsules, light brown body and brown cap.

The contents of the capsules are a yellow-brown or brown homogeneous mass from an oily to a denser consistency with a characteristic odor.

Pharmaco-therapeutic group

N4 The drug is used in gastroenterology, dermatology, neurology, cardiology.

Gastroenterology: Fatty degeneration of the liver of various etiology

acute and chronic hepatitis (except viral)

cirrhosis of the liver

toxic liver damage - alcoholic, narcotic, medicinal

dysfunction of hepatocytes (as a complication in other diseases)

pre- and postoperative treatment in operations in the hepatobiliary zone.

Dermatology: Psoriasis as part of complex therapy.

Neurology: Atherosclerosis of cerebral vessels as part of complex therapy.

Endocrinology: Diabetes mellitus as part of complex therapy

exhaustion, dystrophy.

Cardiology: Atherosclerosis of the coronary arteries as part of complex therapy.

Application during pregnancy and during breastfeeding

There have been no studies confirming the safety of EslidinВ® for the fetus and the safety for the baby during breastfeeding.

The use of the drug during pregnancy and lactation is possible only as directed by a doctor in cases where the intended benefit to the mother outweighs the possible risk to the fetus and child.

Dosage form

EslidinВ® capsules, 10 capsules in a blister strip packaging made of polyvinyl chloride film and aluminum foil.

30, 50, 60 or 100 capsules in a polymer jar.

30 capsules in a glass jar OS (orange glass) with a triangular rim, 50 or 60 capsules in a glass jar with a screw neck.

Each can, or 3, or 5, or 6 or 10 blisters, together with instructions for medical use of the drug, are placed in a cardboard box.

Shelf life

2 years.

Do not use the drug after the expiration date indicated on the package.

Category

Gastrointestinal tract

Name ENG

ESLIDINE

Clinical and pharmacological group

Hepatoprotector

A drug that regulates lipid and carbohydrate metabolism

ATX code

Combination of drugs for the treatment of liver and biliary tract diseases

Dosage

100mg + 300mg

Structure

One capsule contains: lipoid PPL-400 (phospholipids) (in terms of 100% content of polyunsaturated phospholipids from soy lecithin - PPL fraction) 300 mg, methionine (in terms of 100% substance) 100 mg, soybean oil up to 550 mg.

.Capsules hard gelatinous: titanium dioxide, iron oxide black, iron oxide red, iron oxide yellow, purified water, gelatin.

Indications

The drug is used in gastroenterology, dermatology, neurology, cardiology.

Contraindications

Hypersensitivity (hypersensitivity) to the components of the drug

severe hepatic insufficiency, hepatic encephalopathy, viral hepatitis, children under 3 years of age.

It is possible to use with caution during pregnancy and in children from 3 to 7 years old, as well as in case of renal failure (due to the danger of an increase in hyperazotemia).

Storage conditions and periods

In a dry, dark place at a temperature not exceeding 25 В° C.

Keep out of the reach of children.

INN / Active ingredient

Methionine, phospholipids

Specifications

Category

Hepatoprotectors

Release form

Capsules

Manufacturer country

Russia

Package quantity, pcs

thirty

Scope of application

Gastroenterology

,

Neurology

,

Cardiology

,

Dermatology

Minimum age from

3 years old

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Nizhpharm

The amount of the dosage form in the primary package

10 pieces.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Hepatoprotective agent

Dosage form

Capsules

The target audience

Children

Expiration date in days

730

Package weight, g

thirty

Scope of the medicinal product

:

Gastrointestinal tract

,

Dermatology

,

Neurology, psychiatry

,

Heart, vessels, blood

Mode of application

:

The drug is taken orally, during meals, swallowing whole, with a sufficient amount of water.

For liver diseases, atherosclerosis of the coronary arteries and cerebral vessels, diabetes mellitus, degeneration and exhaustion, take 2 capsules 3 times a day.

The recommended course of treatment is 3 months, the minimum is 1 month.

For psoriasis - 2 capsules 3 times a day.

The recommended course of treatment is 2 weeks.

Children over 7 years of age with liver diseases, diabetes mellitus, fatty degeneration of the liver - 2 capsules 3 times a day, for 1 - 3 months.

For psoriasis, children over 7 years old - 2 capsules 3 times a day, for 2 weeks.

The use of the drug in children from 3 to 7 years old - 1 capsule 3 times a day for 1-3 months.

Anatomical and therapeutic characteristics

:

A05C Drugs for the treatment of liver and biliary tract diseases in combination

Dosage (volume) of the substance in the preparation

:

Lipoid PPL-400 (phospholipids) (in terms of 100% content of polyunsaturated phospholipids from soy lecithin - PPL fraction) 300 mg, methionine (in terms of 100% substance) 100 mg, soybean oil up to 550 mg

Information on technical characteristics, delivery set, country of manufacture